Dr. Sowemimo Discusses the Future of Weight Loss Treatment on International Health Podcast

Bariatric Surgeon and Obesity Medicine Expert Shares Insights on GLP-1 Medications, Weight Loss Surgery and the Evolving Science of Obesity Care

 

 

The conversation around weight loss has changed dramatically in recent years.

Today, obesity is increasingly recognized as a chronic disease requiring long-term medical management rather than a simple matter of willpower. New treatment options, including GLP-1 medications and advanced bariatric surgery techniques, are helping patients achieve meaningful and lasting improvements in their health.

To explore these developments, board-certified bariatric surgeon and obesity medicine expert Dr. Seun Sowemimo recently joined UK physician Dr. Andrew Greenland on Voices in Health and Wellness, a globally-recognized podcast addressing the intersection of medicine, lifestyle, and human potential — with clinicians, scientists, and thinkers shaping the future of care.

Listen to the podcast here with Dr. Sowemimo:
https://www.buzzsprout.com/2489689/episodes/19357289

 

Dr. Seun: The Evolution of Obesity Treatment

Dr. Sowemimo is a top patient rated bariatric, gallbladder and hernia surgeon in New Jersey

During the discussion, Dr. Sowemimo addressed several of the most important topics shaping obesity care today, including:

  • The growing role of GLP-1 medications such as semaglutide and tirzepatide
  • How bariatric surgery continues to deliver the most durable long-term weight loss outcomes for many patients
  • Common misconceptions about obesity and weight management
  • Why obesity should be viewed as a complex metabolic disease
  • The importance of individualized treatment plans

As public awareness of obesity treatment options grows, patients are often overwhelmed by conflicting information. The podcast offers practical, evidence-based insights into how modern weight loss programs are helping patients improve their health and quality of life.

 

Dr. Seun: Bariatric Surgery and GLP-1 Medications: Partners, Not Competitors

One of the key themes of the conversation was that bariatric surgery and GLP-1 medications should not be viewed as competing treatments.

Instead, both tools can play valuable roles depending on a patient’s medical history, weight loss goals and overall health profile.

At Prime Surgicare, Dr. Sowemimo works with patients seeking both surgical and non-surgical weight loss solutions. His practice offers comprehensive evaluations designed to help patients determine the most appropriate treatment pathway.

Learn more about Dr. Sowemimo’s medical and surgical weight loss programs:
https://primesurgicare.com/weight-loss/

 

About New Jersey Surgeon Dr. Seun Sowemimo

 

Dr. Sowemimo is a New Jersey board-certified bariatric surgeon, gallbladder surgeon and hernia surgeon.

Dr. Seun Sowemimo is a New Jersey board-certified bariatric surgeon, general surgeon and obesity treatment specialist serving patients throughout New Jersey. He performs advanced minimally-invasive procedures including gastric sleeve surgery, gastric bypass surgery, revisional bariatric surgery, hernia repair and gallbladder surgery.

In addition to surgical care, he offers comprehensive medical weight loss programs that include GLP-1 medications when appropriate.

Click here to learn more about Dr. Sowemimo:


For media inquiries, podcast appearances, radio and television appearances or expert commentary, contact Stephanie Duncan at MPW Communications at 732-763-1866.

 

Listen to the UK-Based Voices in Health & Wellness Podcast

The complete interview with Dr. Andrew Greenland is available here:

https://www.buzzsprout.com/2489689/episodes/19357289

Whether you are considering weight loss surgery, exploring GLP-1 medications or simply interested in the future of obesity treatment, the discussion provides valuable insights into one of healthcare’s most rapidly evolving fields.

Share this post:
Facebook
Twitter
LinkedIn

Related Posts You May Like